Gouty Arthritis (Gout) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Gouty Arthritis Pipeline Drugs Market Overview
Gout is a type of inflammatory arthritis that is triggered by the crystallization of uric acid within the joints. It is associated with hyperuricemia, often because of the overproduction or underexcretion of uric acid by the body. Uric acid is the product of the metabolism of purine-containing compounds, such as deoxyribonucleic acid and ribonucleic acid. Uric acid is a weak acid and exists largely in the form of a urate anion (an ionized form of uric acid) at the physiologic pH of 7.4. Hyperuricemia is not only the risk factor for gout, but other factors such as older age, male sex, obesity, purine diet, alcohol, medications, comorbid diseases, and genetics cause gout.
The gouty arthritis marketed and pipeline drugs assessment report provides a data-driven overview of the current and future competitive landscape in gouty arthritis therapeutics.
Gouty Arthritis Marketed and Pipeline Drugs Market Overview by Mechanism of Action
The major marketed and pipeline drugs for treating gouty arthritis are transporter inhibitor, receptor agonist, receptor antagonist, ion channel blocker, enzyme inhibitor, ligand depletor, cytotoxic to cell, biological factor inhibitor, enzyme activator, and protein & peptide inhibitor.
Gouty Arthritis Marketed and Pipeline Drugs Market Analysis by Mechanism of Action
For more mechanism of action insights, download a free report sample
Gouty arthritis Marketed and Pipeline Drugs Market Overview by Routes of Administration
The major marketed and pipeline drugs for treating gouty arthritis are oral therapies, injections, suppository therapies, topical therapies, and inhalational therapies.
Gouty Arthritis Marketed and Pipeline Drugs Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Market Report Scope
Major Mechanism of Action | Transporter Inhibitor, Receptor Agonist, Receptor Antagonist, Ion Channel Blocker, Enzyme Inhibitor, Ligand Depletor, Cytotoxic to Cell, Biological Factor Inhibitor, Enzyme Activator, and Protein & Peptide Inhibitor |
Major Routes of Administration | Oral Therapies, Injections, Suppository Therapies, Topical Therapies, and Inhalational Therapies. |
Scope
GlobalData’s Gouty Arthritis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, and Route of Administration
- Product Profiles with Sales Forecast
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the gouty arthritis market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global gouty arthritis market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What are the major mechanisms of action in gouty arthritis marketed and pipeline drugs market?
The major marketed and pipeline drugs for treating gouty arthritis are transporter inhibitor, receptor agonist, receptor antagonist, ion channel blocker, enzyme inhibitor, ligand depletor, cytotoxic to cell, biological factor inhibitor, enzyme activator, and protein & peptide inhibitor.
-
What are the major routes of administration in gouty arthritis marketed and pipeline drugs market?
The major marketed and pipeline drugs for treating gouty arthritis are oral therapies, injections, suppository therapies, topical therapies, and inhalational therapies.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Gouty Arthritis (Gout) reports![](https://www.globaldata.com/store/wp-content/uploads/sites/2/blue_1bg2.webp)
![](https://www.globaldata.com/store/wp-content/uploads/sites/2/blue_1bg2.webp)